Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy

por Di Cosimo, Serena
Publicado 2009

Concomitant medications and circulating tumor cells: friends or foes?

por Di Cosimo, Serena, Cappelletti, Vera
Publicado 2023

Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients

por Tessari, Anna, Palmieri, Dario, Di Cosimo, Serena
Publicado 2013

CDK 4/6 inhibitors mired in uncertainty in HR positive and HER2 negative early breast cancer

por Di Cosimo, Serena, Porcu, Luca, Cardoso, Fatima
Publicado 2020

Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

por Di Cosimo, Serena, Porcu, Luca, Malfettone, Andrea, Cortés, Javier, Miceli, Rosalba
Publicado 2020

The worldwide impact of COVID-19 on cancer care: A meta-analysis of surveys published after the first wave of the pandemic

por Di Cosimo, Serena, Susca, Nicola, Apolone, Giovanni, Silvestris, Nicola, Racanelli, Vito
Publicado 2022

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019

por Di Cosimo, Serena, Malfettone, Andrea, Pérez-García, José M., Llombart-Cussac, Antonio, Miceli, Rosalba, Curigliano, Giuseppe, Cortés, Javier
Publicado 2020

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective

por Fogazzi, Valentina, Kapahnke, Marcel, Cataldo, Alessandra, Plantamura, Ilaria, Tagliabue, Elda, Di Cosimo, Serena, Cosentino, Giulia, Iorio, Marilena V.
Publicado 2022

Psychosocial factors associated with workability after surgery in cancer survivors: An explorative study

por Silvaggi, Fabiola, Mariniello, Arianna, Leonardi, Matilde, Silvani, Antonio, Lamperti, Elena, Di Cosimo, Serena, Folli, Secondo, Trapani, Anna, Schiavolin, Silvia
Publicado 2023

Direct and indirect effects of COVID-19 on short-term mortality of breast cancer patients

por Di Cosimo, Serena, Ljevar, Silva, Trama, Annalisa, Bernasconi, Alice, Lasalvia, Paolo, De Santis, Maria Carmen, Cappelletti, Vera, Miceli, Rosalba, Apolone, Giovanni
Publicado 2023

COVID‐19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020

por Trama, Annalisa, Bernasconi, Alice, Botta, Laura, Di Cosimo, Serena, Miceli, Rosalba, Claps, Melanie, Badenchini, Fabio, Lillini, Roberto, Rubino, Massimiliano, Lasalvia, Paolo
Publicado 2022

Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma

por Silvestri, Marco, Nghia Vu, Trung, Nichetti, Federico, Niger, Monica, Di Cosimo, Serena, De Braud, Filippo, Pruneri, Giancarlo, Pawitan, Yudi, Calza, Stefano, Cappelletti, Vera
Publicado 2023

Nobody dares stopping clinical research, not even COVID-19

por Malfettone, Andrea, Di Cosimo, Serena, Pérez-García, José Manuel, García, Alicia, Sampayo-Cordero, Miguel, Mina, Leonardo, Herrero, Carolina, Llombart-Cussac, Antonio, Cortés, Javier
Publicado 2021

A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy

por Zambelli, Alberto, Cazzaniga, Marina, La Verde, Nicla, Munzone, Elisabetta, Antonazzo, Ippazio Cosimo, Mantovani, Lorenzo Giovanni, Di Cosimo, Serena, Mancuso, Anna, Generali, Daniele, Cortesi, Paolo Angelo
Publicado 2023

Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study

por La Verde, Nicla, Biagioli, Elena, Gerardi, Chiara, Cordovana, Andrea, Casiraghi, Chiara, Floriani, Irene, Bernardin, Elena, Farina, Gabriella, Di Cosimo, Serena, Dazzani, Maria Chiara, Gherardi, Giorgio
Publicado 2016

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

por Triulzi, Tiziana, Regondi, Viola, De Cecco, Loris, Cappelletti, Maria Rosa, Di Modica, Martina, Paolini, Biagio, Lollini, Pier Luigi, Di Cosimo, Serena, Sfondrini, Lucia, Generali, Daniele, Tagliabue, Elda
Publicado 2018

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer

por Silvestri, Marco, Dugo, Matteo, Vismara, Marta, De Cecco, Loris, Lanzoni, Davide, Vingiani, Andrea, Folli, Secondo, De Santis, Maria Carmen, de Braud, Filippo, Pruneri, Giancarlo, Di Cosimo, Serena, Cappelletti, Vera
Publicado 2022

Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration

por Triulzi, Tiziana, De Cecco, Loris, Sandri, Marco, Prat, Aleix, Giussani, Marta, Paolini, Biagio, Carcangiu, Marialuisa L., Canevari, Silvana, Bottini, Alberto, Balsari, Andrea, Menard, Sylvie, Generali, Daniele, Campiglio, Manuela, Di Cosimo, Serena, Tagliabue, Elda
Publicado 2015

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy

por Di Cosimo, Serena, Appierto, Valentina, Silvestri, Marco, Pruneri, Giancarlo, Vingiani, Andrea, Perrone, Federica, Busico, Adele, Folli, Secondo, Scaperrotta, Gianfranco, de Braud, Filippo Guglielmo, Bianchi, Giulia Valeria, Cavalieri, Stefano, Daidone, Maria Grazia, Dugo, Matteo
Publicado 2019

Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial

por Di Cosimo, Serena, Porcu, Luca, Agbor-tarh, Dominique, Cinieri, Saverio, Franzoi, Maria Alice, De Santis, Maria Carmen, Saura, Cristina, Huober, Jens, Fumagalli, Debora, Izquierdo, Miguel, Piccart, Martine, Daidone, Maria Grazia, de Azambuja, Evandro
Publicado 2020